Vaxart reduces workforce and pauses COVID-19 vaccine development
The developer of oral vaccines announces a restructure of its business priorities, as it looks to conserve cash to progress its norovirus candidate.
Archives for March 20, 2023
EDSA outlines supply danger to 100 medicines after manufacturer bankruptcy
Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.
BMS grants $10m in funding to address health disparity
The funding will be split between 17 US non-profit organizations this year, as the company reveals the broader progress it has made towards its long-term inclusion and diversity goals.
Diversity in clinical trials has actually dropped since 2012, IQVIA finds
Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.
Bluepharma invests €30M in industrial unit for oncology drugs
Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.